By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aerie Pharmaceuticals, Inc. 

1140 Route 22 East
Suite 303
Bridgewater  New Jersey  08807  U.S.A.
Phone: 908-685-0069 Fax: 908-685-0087


SEARCH JOBS


Industry
Pharmaceutical






Company News
Aerie (AERI) To Announce First Quarter 2016 Financial Results And Host Conference Call On Monday, May 2, 2016 4/25/2016 10:56:48 AM
Aerie (AERI) To Present At The 15th Annual Needham Healthcare Conference 4/5/2016 9:08:49 AM
Aerie (AERI) Initiates Second Phase 3 Registration Trial Of Roclatan (Netarsudil/Latanoprost Ophthalmic Solution) 0.02%/0.005% 3/28/2016 9:19:16 AM
SoCal's Aerie (AERI) Reports Positive Safety Data for Rhopressa 3/18/2016 6:36:24 AM
Aerie (AERI) Announces Availability On Its Website Of Abstracts To Be Presented At The American Glaucoma Society 26th Annual Meeting 3/3/2016 10:37:30 AM
Aerie (AERI) Reports Year End 2015 Financial Results And Provides Business Update 3/2/2016 12:33:27 PM
Aerie (AERI) Announces Four New Abstracts To Be Presented At The American Glaucoma Society 26th Annual Meeting Next Week 2/23/2016 11:13:14 AM
Aerie (AERI) Announces Four New Abstracts To Be Presented At The American Glaucoma Society 26th Annual Meeting Next Week 2/23/2016 11:10:57 AM
Aerie (AERI) To Announce Fourth Quarter And Year End 2015 Financial Results And Host Conference Call On Tuesday, March 1, 2016 2/22/2016 12:16:25 PM
Aerie (AERI) Reports Positive Rhopressa QD (netarsudil ophthalmic solution) 0.02% 12 Month Interim Safety Results For Rocket 2 2/18/2016 10:31:38 AM
123456789
//-->